{
  "pmcid": "5526458",
  "sha256": "cec9c6b27bb87b7bc974e439e99aa95759e5ef3db60f538b447cedeff8249012",
  "timestamp_utc": "2025-11-09T22:46:48.093554+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 10.380716814159296,
    "reading_ease": 40.76461504424779,
    "word_count": 226
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "This randomised controlled trial aimed to examine the impact of timing of first massive transfusion (MT) cooler delivery on patient outcomes."
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "patients predicted to receive MT were randomised to two transfusion ratios (1:1:1 vs. 1:1:2) as per the PROPPR trial."
      },
      "Participants": {
        "score": 2,
        "evidence": "Conducted at 12 level-1 trauma centers, patients predicted to receive MT were randomised."
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomised to two transfusion ratios (1:1:1 vs. 1:1:2)"
      },
      "Objective": {
        "score": 1,
        "evidence": "This randomised controlled trial aimed to examine the impact of timing of first massive transfusion (MT) cooler delivery on patient outcomes."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was mortality, measured at 24 hours and 30 days."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was performed using a centralised system, and allocation was concealed."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Blinding was not applicable."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "A total of 680 patients were randomised."
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "Delays in MT activation and cooler delivery were associated with prolonged time to hemostasis (coef 1.09, p=0.001 and coef 1.16, p<0.001) and increased mortality (OR 1.02, p=0.009 and OR 1.02, p=0.012)."
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were reported."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: [Trial registration number]."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: [Source of funding]."
      }
    },
    "total_score": 15,
    "max_score": 25
  }
}